SCM
HZNP

SevenOneSeven Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

SevenOneSeven Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,239
Closed -$355K – 59
2021
Q3 		$355K Buy
3,239
+67
+2% +$6.96K 0.9% 29
2021
Q2 		$297K Buy
3,172
+756
+31% +$69.6K 0.77% 41
2021
Q1 		$222K Buy
+2,416
New +$204K 0.82% 39

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

SevenOneSeven Capital Management's HZNP Position: Q4 2021 in Review

SevenOneSeven Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2021, closing a stake of 3,239 shares — an estimated $355K sold.

SevenOneSeven Capital Management first reported a position in HZNP in Q1 2021 and held it in 3 quarters. The position peaked at $355K in Q3 2021. 611 funds tracked by Wall St. Rank hold HZNP as of Q4 2021.

  • SevenOneSeven Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2021 after selling out during the quarter.
  • SevenOneSeven Capital Management sold 3,239 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2021, an estimated $355K.
  • SevenOneSeven Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2021 and held it in 3 quarters.
  • SevenOneSeven Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $355K in Q3 2021.
  • 611 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2021.

Based on SevenOneSeven Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.